Cargando…
The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?
Fever has been reported as a common symptom occurring in COVID-19 illness. Over the counter antipyretics such as ibuprofen and acetaminophen are often taken by individuals to reduce the discomfort of fever. Recently, the safety of ibuprofen in COVID-19 patients has been questioned due to anecdotal r...
Autores principales: | Jamerson, Brenda D., Haryadi, T. Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247463/ https://www.ncbi.nlm.nih.gov/pubmed/32505846 http://dx.doi.org/10.1016/j.mehy.2020.109880 |
Ejemplares similares
-
Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
por: Jamerson, Brenda D., et al.
Publicado: (2020) -
Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study
por: Abu Esba, Laila Carolina, et al.
Publicado: (2020) -
Ibuprofen use and clinical outcomes in COVID-19 patients
por: Rinott, E., et al.
Publicado: (2020) -
Worse Blood Pressure Levels and Control During Nonsummer Months in Rigorously Treated Patients With Hypertension: The ACCOMPLISH Trial
por: Brook, Robert D., et al.
Publicado: (2023) -
Acute encephalopathy is associated with worse outcomes in COVID-19 patients
por: Shah, Vishank Arun, et al.
Publicado: (2020)